These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 4098769

  • 1. [Use of hirudin in clinical coagulation laboratories].
    Walsmann P, Vogel G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(2):143-52. PubMed ID: 4098769
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The use of the specific thrombin inhibitor hirudin in diagnostic and biochemical studies].
    Walsmann P.
    Pharmazie; 1988 Nov; 43(11):737-44. PubMed ID: 3073391
    [No Abstract] [Full Text] [Related]

  • 6. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE, Mitterer A, Schlokat U, Grillberger L, Reiter M, Mundt W, Dorner F, Eibl J.
    Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
    [Abstract] [Full Text] [Related]

  • 7. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F.
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [Abstract] [Full Text] [Related]

  • 8. [Comparative properties of hirudin from whole leeches and from leech heads and bodies].
    Baskova IP, Cherkesova DU.
    Biokhimiia; 1980 Feb; 45(2):267-72. PubMed ID: 7388067
    [Abstract] [Full Text] [Related]

  • 9. The direct thrombin inhibitor hirudin.
    Greinacher A, Warkentin TE.
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H, Markwardt F, Perlewitz J.
    Thromb Diath Haemorrh; 1969 Dec 31; 22(3):552-68. PubMed ID: 5382290
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. THE ACTIVATION OF PROACCELERIN.
    DE BERGSAGEL DE, NOCKOLDS ER.
    Br J Haematol; 1965 Jul 31; 11():395-410. PubMed ID: 14317432
    [No Abstract] [Full Text] [Related]

  • 14. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA, Lormeau JC, Craven S, Dewar L, Anvari N.
    Thromb Haemost; 1994 Dec 31; 72(6):862-8. PubMed ID: 7740455
    [Abstract] [Full Text] [Related]

  • 15. Laboratory use of hirudin.
    Stocker K.
    Semin Thromb Hemost; 1991 Apr 31; 17(2):113-21. PubMed ID: 1722908
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A functional clotting assay to monitor the hirudin dosage.
    Zakir RM, Hoffman W, Bhatt BA, Spillert CR.
    Blood Coagul Fibrinolysis; 2007 Mar 31; 18(2):119-23. PubMed ID: 17287627
    [Abstract] [Full Text] [Related]

  • 18. [The use of prothrombin determination with hirudin in the supervision of treatment with dicoumarol derivatives].
    MARKWARDT F, WENZEL G.
    Blut; 1961 Apr 31; 7():37-42. PubMed ID: 13766979
    [No Abstract] [Full Text] [Related]

  • 19. [Biochemical and pharmacological aspects of the thrombin inhibitor hirudin].
    Walsmann P, Markwardt F.
    Pharmazie; 1981 Oct 31; 36(10):653-60. PubMed ID: 7031705
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.